{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:49:23Z","timestamp":1792259363460,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018601","name":"Canolfan Ymchwil Canser Cymru","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012068","name":"Health and Care Research Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clon.2024.103693","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T02:12:08Z","timestamp":1731636728000},"page":"103693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Reconsidering the Role of Radiotherapy for Inoperable Gastric Cancer: A Systematic Review of Gastric Radiotherapy Given With Definitive and Palliative Intent"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-6521","authenticated-orcid":false,"given":"A.","family":"Case","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8708-3301","authenticated-orcid":false,"given":"F.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4155-1741","authenticated-orcid":false,"given":"H.","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-1756","authenticated-orcid":false,"given":"T.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-7243","authenticated-orcid":false,"given":"R.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7750-5320","authenticated-orcid":false,"given":"S.","family":"Gwynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clon.2024.103693_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2S","key":"10.1016\/j.clon.2024.103693_bib5","article-title":"Gastric Radiotherapy in the UK - Current Practice and Opinion on Future Directions","volume":"117","author":"Case","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.clon.2024.103693_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"28","key":"10.1016\/j.clon.2024.103693_bib7","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1200\/JCO.2014.58.3930","article-title":"Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses","volume":"33","author":"Park","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2024.103693_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","article-title":"Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial","volume":"19","author":"Cats","year":"2018","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clon.2024.103693_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","article-title":"A\u00a0randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial\u2606","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2024.103693_bib10","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative Chemoradiotherapy for Resectable Gastric Cancer","author":"Leong","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.clon.2024.103693_bib11","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1245\/s10434-017-5830-6","article-title":"TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG","volume":"24","author":"Leong","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1186\/s12885-018-4770-2","volume":"18","author":"Slagter","year":"2018","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.clon.2024.103693_bib13","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1200\/JCO.2004.01.015","article-title":"Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma","volume":"22","author":"Ajani","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1200\/JCO.2005.01.305","article-title":"Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome","volume":"23","author":"Ajani","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.clon.2024.103693_bib15","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1200\/JCO.2006.06.4840","article-title":"Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response","volume":"24","author":"Ajani","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2024.103693_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","article-title":"Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial","volume":"81","author":"Stahl","year":"2017","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.clon.2024.103693_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2024.103693_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2021.05.020","article-title":"Oxaliplatin\/capecitabine or carboplatin\/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial","volume":"153","author":"Mukherjee","year":"2021","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.clon.2024.103693_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clon.2010.12.001","article-title":"Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer","volume":"23","author":"Gwynne","year":"2011","journal-title":"Clin Oncol (R Coll Radiol"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"10","key":"10.1016\/j.clon.2024.103693_bib22","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jep.12889","article-title":"Critical appraisal of nonrandomized studies-A review of recommended and commonly used tools","volume":"25","author":"Quigley","year":"2019","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.clon.2024.103693_bib24","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2024.103693_bib25","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2020\/e1644","article-title":"Palliative radiotherapy for gastric cancer: Is there a dose relationship between bleeding response and radiotherapy?","volume":"75","author":"Viani","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.clon.2024.103693_bib26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ijrobp.2017.03.032","article-title":"Multicenter Phase 2 Study of Peri-Irradiation Chemotherapy Plus Intensity Modulated Radiation Therapy With Concurrent Weekly Docetaxel for Inoperable or Medically Unresectable Nonmetastatic Gastric Cancer","volume":"98","author":"Liu","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib27","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3892\/mco.2014.348","article-title":"Radiotherapy and chemoradiotherapy as a novel option for the treatment of locally advanced inoperable gastric adenocarcinoma: A phase II study","volume":"2","author":"Wydmanski","year":"2014","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0360-3016(99)00436-8","article-title":"Paclitaxel and concurrent radiation for gastric cancer","volume":"46","author":"Safran","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2024.103693_bib29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.12669\/pjms.38.5.5311","article-title":"Clinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer","volume":"38","author":"Chen","year":"2022","journal-title":"Pak J Med Sci"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4149\/neo_2012_048","article-title":"Phase I study of docetaxel, cisplatin and concurrent radiotherapy for locally advanced gastric adenocarcinoma","volume":"59","author":"Xing","year":"2012","journal-title":"Neoplasma"},{"issue":"8","key":"10.1016\/j.clon.2024.103693_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.bjc.6601311","article-title":"Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin\/cisplatin\/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation","volume":"89","author":"Leong","year":"2003","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.clon.2024.103693_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010786","article-title":"A\u00a0clinical analysis of systemic chemotherapy combined with radiotherapy for advanced gastric cancer","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clon.2024.103693_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2018.04.012","article-title":"Potentially curable gastric adenocarcinoma treated without surgery","volume":"98","author":"Mizrak Kaya","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1308\/rcsann.2016.0305","article-title":"Usefulness of chemoradiotherapy for inoperable gastric cancer","volume":"99","author":"Taki","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000338318","article-title":"Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience","volume":"82","author":"Suzuki","year":"2012","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.clon.2024.103693_bib36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.6004\/jnccn.2018.7030","article-title":"Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer","volume":"16","author":"Li","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/cam4.2021","article-title":"Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial","volume":"8","author":"Tey","year":"2019","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00280-009-0963-3","article-title":"A\u00a0phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma","volume":"64","author":"Yoshikawa","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.clon.2024.103693_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10120-021-01254-w","article-title":"Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3)","volume":"25","author":"Saito","year":"2022","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12904-022-00943-2","article-title":"Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study","volume":"21","author":"Takeda","year":"2022","journal-title":"BMC Palliat Care"},{"issue":"3","key":"10.1016\/j.clon.2024.103693_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00595-022-02567-8","article-title":"Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer","volume":"53","author":"Yagi","year":"2023","journal-title":"Surg Today"},{"issue":"12","key":"10.1016\/j.clon.2024.103693_bib42","article-title":"The Impact of Palliative Radiation Therapy on Patients With Advanced Gastric Cancer: Results of a Retrospective Cohort Study","volume":"14","author":"Katano","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.clon.2024.103693_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12029-021-00632-y","article-title":"Verification of the Utility of Palliative Radiotherapy for Hemostasis of Gastric Cancer Bleeding: a Case Control Study","volume":"53","author":"Sugita","year":"2022","journal-title":"J\u00a0Gastrointest Cancer"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib44","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/biomedicines10061394","article-title":"Palliative Radiotherapy for Bleeding from Unresectable Gastric Cancer Using Three-Dimensional Conformal Technique","volume":"10","author":"Kawabata","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12885-021-08145-4","article-title":"Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer","volume":"21","author":"Yu","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13014-021-01884-5","article-title":"Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer","volume":"16","author":"Lee","year":"2021","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/pmr.2021.0041","article-title":"Hemostatic Effect of Palliative Radiation Therapy in Preventing Blood Transfusions from Bleeding Occurring within Advanced Gastric Cancer","volume":"2","author":"Mitsuhashi","year":"2021","journal-title":"Palliat Med Rep"},{"issue":"5","key":"10.1016\/j.clon.2024.103693_bib48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10120-020-01058-4","article-title":"Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer","volume":"23","author":"Sasaki","year":"2020","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib49","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10147-018-1317-0","article-title":"Efficacy of palliative radiotherapy and chemo-radiotherapy for unresectable gastric cancer demonstrating bleeding and obstruction","volume":"23","author":"Hiramoto","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12885-017-3508-x","article-title":"Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000475550","article-title":"101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy","volume":"93","author":"Mizrak Kaya","year":"2017","journal-title":"Oncology"},{"issue":"22","key":"10.1016\/j.clon.2024.103693_bib52","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000118","article-title":"Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era","volume":"93","author":"Tey","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clon.2024.103693_bib53","first-page":"53","article-title":"Palliative haemostatic radiotherapy for advanced cancer of the stomach","volume":"5","author":"Choi","year":"2012","journal-title":"J\u00a0Pain Manage"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00432-010-0866-z","article-title":"Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate?","volume":"137","author":"Asakura","year":"2011","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2024.103693_bib55","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/030089160909500615","article-title":"Radiation therapy for gastric cancer bleeding","volume":"95","author":"Lee","year":"2009","journal-title":"Tumori"},{"issue":"8","key":"10.1016\/j.clon.2024.103693_bib56","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-009-0553-0","article-title":"Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience","volume":"135","author":"Hashimoto","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2024.103693_bib57","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02841860701621233","article-title":"Clinical benefit of palliative radiation therapy in advanced gastric cancer","volume":"47","author":"Kim","year":"2008","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S2468-1253(21)00004-2","article-title":"Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial","volume":"6","author":"Adamson","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.clon.2024.103693_bib59","doi-asserted-by":"crossref","first-page":"25797","DOI":"10.18632\/oncotarget.15554","article-title":"Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis","volume":"8","author":"Tey","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.clon.2024.103693_bib60","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clon.2024.103693_bib61","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1038\/s41467-022-34403-5","article-title":"The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction","volume":"13","author":"Tang","year":"2022","journal-title":"Nat Commun"},{"issue":"15_suppl","key":"10.1016\/j.clon.2024.103693_bib62","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2021.39.15_suppl.4040","article-title":"SHARED: Efficacy and safety of sintilimab in combination with concurrent chemoradiotherapy (cCRT) in patients with locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma","volume":"39","author":"Wei","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2024.103693_bib63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4143\/crt.2014.174","article-title":"Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer","volume":"47","author":"Hingorani","year":"2015","journal-title":"Cancer Res Treat"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:36:55Z","timestamp":1737319015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655524004898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":60,"alternative-id":["S0936655524004898"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2024.103693","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconsidering the Role of Radiotherapy for Inoperable Gastric Cancer: A Systematic Review of Gastric Radiotherapy Given With Definitive and Palliative Intent","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2024.103693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"103693"}}